Search
for
Sort by
Research 301–330 of 1000+
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Survey of pediatric dermatologist views on treatment for alopecia areata
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Sequential small-molecule therapy for lymphocytic cicatricial alopecia: A multicenter prospective cohort pilot study
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Alopecia Areata: An Update on Treatment Options for Children
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Vitiligo—Current Treatment Options and Future Perspectives
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Resident Memory T Cells in Autoimmune Skin Diseases
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Novel potential therapeutic targets of alopecia areata
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Hypotrichosis 14: novel variants of the LSS gene in five Chinese families and insights from literature review
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Evidence for the off-label use of tofacitinib in alopecia areata
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis